Prognostic Value of EGFR Mutation and ERCC1 in Patients with Non-Small Cell Lung Cancer Undergoing Platinum-Based Chemotherapy

類似資料

• Association of EGFR Exon 19 Deletion and EGFR-TKI Treatment Duration with Frequency of T790M Mutation in EGFR-Mutant Lung Cancer Patients
  著者:: Matsuo, Norikazu, 等
  出版事項: (2016)
• Chemotherapy for non-small cell lung cancer complicated by idiopathic interstitial pneumonia
  著者:: KINOSHITA, TAKASHI, 等
  出版事項: (2012)
• FGFR1 activation is an escape mechanism in human lung cancer cells resistant to afatinib, a pan-EGFR family kinase inhibitor
  著者:: Azuma, Koichi, 等
  出版事項: (2014)
• Humoral Immune Responses to EGFR-Derived Peptides Predict Progression-Free and Overall Survival of Non-Small Cell Lung Cancer Patients Receiving Gefitinib
  著者:: Azuma, Koichi, 等
  出版事項: (2014)
• Digital PCR analysis of plasma cell-free DNA for non-invasive detection of drug resistance mechanisms in EGFR mutant NSCLC: Correlation with paired tumor samples
  著者:: Ishii, Hidenobu, 等
  出版事項: (2015)